tetano
Editor, Senior Moderator
J Korean Med Sci
. 2023 May 8;38(18):e134.
doi: 10.3346/jkms.2023.38.e134. Concurrent Subacute Thyroiditis and Graves' Disease After COVID-19: A Case Report
Eliel Nham[SUP] #[/SUP][SUP] 1 [/SUP], Eyun Song[SUP] #[/SUP][SUP] 2 [/SUP], Hakjun Hyun[SUP] 1 [/SUP], Hye Seong[SUP] 1 [/SUP], Jin Gu Yoon[SUP] 1 [/SUP], Ji Yun Noh[SUP] 1 [/SUP], Joon Young Song[SUP] 1 [/SUP], Hee Jin Cheong[SUP] 1 [/SUP], Woo Joo Kim[SUP] 3 [/SUP]
Affiliations
There are many reports of subacute thyroiditis (SAT) that occurred after the coronavirus disease 2019 (COVID-19), but no such case has been reported in Korea. Moreover, the simultaneous occurrence of SAT and Graves' disease (GD) is rare. Here, we describe a patient who developed SAT and GD after the second episode of COVID-19. A 27-year-old woman with no known history of thyroid disease presented with fever, upper respiratory tract symptoms, and painful neck swelling. Thyroid function tests revealed thyrotoxicosis, and thyroid ultrasound showed heterogeneous echogenicity of enlarged thyroid glands. Her initial clinical presentation was consistent with SAT after viral infection, with typical neck tenderness and spontaneous improvement of thyrotoxicosis without antithyroid drug use. However, this case had some atypical features, such as an elevated thyroid-stimulating immunoglobulin level, relapse of thyrotoxicosis in short-term follow-up, and increased Tc-99m pertechnetate uptake, suggesting the coexistence of GD. About two months after methimazole (15 mg/day) was prescribed, she was lost to follow up again. We report the first case of unusual co-occurrence of SAT and GD following COVID-19.
Keywords: COVID-19; SARS-CoV-2; Thyroiditis.
. 2023 May 8;38(18):e134.
doi: 10.3346/jkms.2023.38.e134. Concurrent Subacute Thyroiditis and Graves' Disease After COVID-19: A Case Report
Eliel Nham[SUP] #[/SUP][SUP] 1 [/SUP], Eyun Song[SUP] #[/SUP][SUP] 2 [/SUP], Hakjun Hyun[SUP] 1 [/SUP], Hye Seong[SUP] 1 [/SUP], Jin Gu Yoon[SUP] 1 [/SUP], Ji Yun Noh[SUP] 1 [/SUP], Joon Young Song[SUP] 1 [/SUP], Hee Jin Cheong[SUP] 1 [/SUP], Woo Joo Kim[SUP] 3 [/SUP]
Affiliations
- PMID: 37158771
- DOI: 10.3346/jkms.2023.38.e134
There are many reports of subacute thyroiditis (SAT) that occurred after the coronavirus disease 2019 (COVID-19), but no such case has been reported in Korea. Moreover, the simultaneous occurrence of SAT and Graves' disease (GD) is rare. Here, we describe a patient who developed SAT and GD after the second episode of COVID-19. A 27-year-old woman with no known history of thyroid disease presented with fever, upper respiratory tract symptoms, and painful neck swelling. Thyroid function tests revealed thyrotoxicosis, and thyroid ultrasound showed heterogeneous echogenicity of enlarged thyroid glands. Her initial clinical presentation was consistent with SAT after viral infection, with typical neck tenderness and spontaneous improvement of thyrotoxicosis without antithyroid drug use. However, this case had some atypical features, such as an elevated thyroid-stimulating immunoglobulin level, relapse of thyrotoxicosis in short-term follow-up, and increased Tc-99m pertechnetate uptake, suggesting the coexistence of GD. About two months after methimazole (15 mg/day) was prescribed, she was lost to follow up again. We report the first case of unusual co-occurrence of SAT and GD following COVID-19.
Keywords: COVID-19; SARS-CoV-2; Thyroiditis.